Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : New Brunswick Scientific Co., Inc. (NBSC) -- Ignore unavailable to you. Want to Upgrade?

To: tuck who wrote (117)	8/9/2000 2:04:48 PM
From: scaram(o)uche	Read Replies (1) \| Respond to of 724

Tuck: No, not a vacation, but nearly as good -- an intimate look at a private company. Lots of fun. Yeah, saw some of the roaches doing laps. Someone at Yahoo called the report a "nightmare". He didn't have enough shares -- I picked up a few at 5 15/16, but not many were available. Report looks fine to me. Sales up 14% quarter-over-quarter with margins still over 40%, and we know that year-over-year is why this sucker is stuck at a capitalization of 40M. Cash is up 400K. Inventories are up 700K. Accounts payable are down 900K which corresponds with the increase in long-term debt. I'm not good at accounting, and don't understand why the 12/31 numbers for accounts payable and working capital don't agree for the first and second quarter reports. They wrote off 800K and total assets went down by 500K. It almost looks like management is trying to make the picture look bad. One comment.... I can't tell if the additional cash due 6/30 from Novo is here. Cheers! Rick